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Summary. The previously described South African type
a-thalassaemia-1 mutation was identified in Indian HbH
patients using a polymerase chain reaction (PCR) strategy.
A multiplex PCR assay was devised to detect heterozygotes
and homozygotes. This a-thalassaemia-1 mutation was
found to be the commonest determinant causing HbH dis-
ease in this population. In one family this mutation was
found in combination with a novel splice donor mutation
a2 IVS I-1 (G fi A). Characterization of the breakpoint
junction sequence revealed, in addition to a 23 kb deletion,
that there was an addition of 160 bp bridging the
breakpoints. Similar to other deletions in the a-globin gene
cluster, there is an Alu repeat-mediated mechanism for the
origin of the deletion.
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The a-thalassaemias are genetic defects characterized by the
decrease or complete suppression of synthesis of the
a-globin polypeptide chains of haemoglobin. They are
the most common single-gene diseases in the world. The
a-globin genes are duplicated (a1 and a2) and located within
the a gene cluster f2)wf1)wa2)wa1)a2)a1)h1 on the
distal short arm region of chromosome 16 (Higgs et al, 1989).
This cluster contains four genes and three pseudogenes.
Deletions of one ()a) or both ()))) of these cis-linked genes are
the most common causes of the a-thalassaemias. Around 25
different two-gene cis deletions () )) and eight single-gene
deletions ()a) have been reported so far in different popula-
tions (Weatherall & Clegg, 2001).
Homozygosity for two gene deletions, which results in the
loss of four a globin genes () )/) )), causes Hb Bart’s
hydrops fetalis syndrome, a condition that generally results in
severe intrauterine anaemia and fetal death in the last
trimester of pregnancy or shortly after birth (Lie-Injo, 1962).
Such pregnancies are accompanied by increased risks of
maternal complications. The loss of three a-globin genes in
the compound heterozygotes of double gene and single gene
deletions ()a/) )) or in the compound heterozygotes of a
double gene deletion and a non-deletional a-thalassaemia
mutation () )/aTa) result in a less severe condition known as
haemoglobin H (HbH) disease which causes chronic haemo-
lytic anaemia of variable severity in children and adults
(Galanello et al, 1992); (Tamary et al, 1998).
Genetic diagnosis of a-thalassaemia is significant, not
only for elucidating the molecular pathology of the condi-
tion, but also for providing carrier detection and prenatal
diagnosis in families at risk of Hb Bart’s hydrops fetalis
syndrome and HbH disease and its interaction with homo-
zygous b-thalassaemia ameliorating or aggravating the
phenotype of these patients.
Measurement of Hb Bart’s levels in cord blood samples
indicated that a-thalassaemia is extremely common among
certain groups in the Indian subcontinent (Misra et al,
1991; Hassall et al, 1998). In tribal populations it reaches a
frequency of 0Æ9, which is as high as that recorded
anywhere in the world (Fodde et al, 1988, 1991). The
DNA analysis carried out in certain regions of India has
shown that )a3Æ7 and )a4Æ2 are the common single gene
deletions, as in other populations (Kulozik et al, 1988). A
23 kb double gene deletion in the a-globin gene cluster that
removes both a2 and a1 genes causing a-thalassaemia-1
())SA), which was originally found in a patient from the
‘cape’ coloured population of South Africa (Vandenplas
et al, 1987), was also detected in an individual from Gujarat
in combination with heterozygous HbS (Drysdale & Higgs,
1988). Isolated cases of HbH disease and Hb Bart’s hydrops
fetalis have been reported in the Indian population. Never-
theless, none of the surveys published so far have docu-
mented the genetic basis of the disease and the actual
frequency of the double gene deletions that are responsible
for HbH disease and Hb Bart’s hydrops fetalis is not known.
We describe here a polymerase chain reaction (PCR)-
based detection of ))SA allele in a cohort of HbH disease
patients in the Indian population. We have characterized
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the breakpoint junction sequence of this deletion and
developed a multiplex PCR protocol for the rapid and
reliable detection of a-thalassaemia deletions in the Indian
population.
PATIENTS AND METHODS
Patients. Seventeen Indian patients with HbH disease,
diagnosed on the basis of clinical and haematological
investigations, and their parents were the subjects of the
present study.
Analysis of seven common deletions. Seven common dele-
tions in the a-globin gene cluster causing a-thalassaemia
()a3Æ7, )a4Æ2, ) )SEA, ) )THAI, ) )FIL, ) )MED and ) )20Æ5)
were analysed in these samples using a previously described
single tube multiplex PCR method (Tan et al, 2001).
Detection of ) )SA mutation. Previous restriction mapping
studies have shown that the left breakpoint of the ) )SA
deletion lies downstream to that of the ) )20Æ5 deletion and
the right breakpoint lies upstream of those of the ) )SEA and
the ) )THAI deletions and downstream of ) )FIL deletion
(Fig 1A). Using the primers described earlier for the
detection of these deletions (Tan et al, 2001), three separate
PCR reactions were carried out with the forward primer for
) )20Æ5 deletion (20Æ5-F) and the reverse primers, for
) )SEA, ) )THAI and ) )FIL deletions (SEA-R, THAI-R and
FIL-R) (Fig 1A) with the genomic DNA extracted from one
of the patients with HbH disease. The amplified product
obtained with 20Æ5-F and THAI-R was sequenced for at least
200 bases away from the forward and reverse primers to
confirm specific amplification of the a-globin gene cluster.
For the characterization of the breakpoint, another PCR was
carried out with the primers a52 and a53 to obtain a
shorter PCR product. This product was sequenced by primer
walking with the primers a52, a53, a50, a55 and a56. The
primers used and their locations are presented in Tables I
and II.
Modified multiplex PCR to detect the common deletions in the
Indian population. We incorporated PCR-based detection of
the ) )SA allele into the single tube multiplex assay
described by Tan et al (2001) to enable simultaneous
screening for the a-thalassaemia deletions prevalent in the
Indian population. Each 50 ll multiplex PCR reaction
contained 200 lmol/l of each dNTP, 1XQ solution (Qiagen,
Hilden, Germany), 1Æ25 U HotStarTaq Polymerase in the
supplied buffer containing 1Æ5 mmol/l MgCl2. 0Æ2 lmol/l of
the primers a52 and a53 were used for the detection of
) )SA. The concentration of the other primers and the
cycling conditions for the amplification reaction were as
described by Tan et al (2001).
Alu repeat analysis at the breakpoint junction. The Alu
repetitive elements near the breakpoints were analysed
using ‘Repeat Masker’ (http://repeatmasker.genome.wash-
ington.edu/cgi-bin/RepeatMasker).
Analysis of point mutations in the a-globin genes. The a2
and a1 genes were amplified as described earlier (Harteveld
et al, 1996) and the amplified products were subjected to
DNA sequencing using the Big Dye terminator kit (Applied
Biosystems, Foster City, CA, USA) on the ABI 310 genetic
analyzer (Applied Biosystems).
A
B
Fig 1. (A) Schematic representation of
a-globin gene cluster indicating the extent of
the ) )SA deletion and its neighbouring dele-
tions. (B) Representative results of multiplex-
PCR from DNA samples with various a-globin
genotypes. Lane 1: aa/aa; Lane 2: aa/) )SA;
Lane 3: )a3Æ7/) )SA; Lane 4: )a4Æ2/) )SA and
Lane 5: molecular weight marker. With the
primers flanking the breakpoints 2022 bp,
1628 bp and 1064 bp were produced for
)a3Æ7, )a4Æ2 and ) )SA deletions respectively.
A 2503 bp fragment from LIZ gene was
amplified in all the genotypes and a 1800 bp
fragment from a2 gene was amplified in
normal individuals (lane 1) and in those who
were heterozygous for the deletions (lane 2)
but not for compound heterozygotes (lanes 3
and 4).
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RESULTS
Initial screening of seven common deletions by the previously
described multiplex PCR (Tan et al, 2001) showed that most
of the patients with HbH disease had a pattern of homozyg-
osity for )a3Æ7 or )a4Æ2 deletions; only one of the parents was
heterozygous for either )a3Æ7 or )a4Æ2 deletions. This discrep-
ancy usually occurs when the patient is compound hetero-
zygous for a large deletion causing a-thalassaemia-1 and
)a3Æ7 or )a4Æ2 deletions. The search for the ) )SA deletion in
these samples by PCR with the primers used for the detection
of the neighbouring deletions resulted in successful amplifi-
cation with the reverse primers for ) )SEA and ) )THAI, but
not with ) )FIL. These results correlated with the genotyping
results of ) )SEA, ) )SA, ) )20Æ5, ) )THAI and ) )FIL
deletions, which showed that the 5¢ breakpoint of the ) )SA
deletion was inside the deleted region of the ) )20Æ5 deletion
and the 3¢ breakpoint was inside the deleted region of the
) )THAI and) )20Æ5 deletions and outside the) )FIL deletion.
The newly developed multiplex PCR revealed that seven of 17
patients had the genotype ) ) SA/) )a3Æ7 while three had
) )SA/)a4Æ2. The results obtained by the multiplex PCR in
different genotypes are presented in Fig 1B. Three patients
from one family had) )SA in combination with a novel splice
donor mutation, IVS 1-1 (G fi A) in the a2 gene, which was
identified by DNA sequencing (Fig 2). Among the other four
patients, two were homozygous for the previously repor-
ted polyadenylation signal mutation in the a2 globin gene
(AATAAA fi AATA) )) and two had the genotypes
) )MED/)a3Æ7 and ) )SEA/)a3Æ7.
Haematological data and genotypes of the patients with
the ) )SA deletion are illustrated in Table III.
The DNA sequencing of the PCR product obtained with the
primers a52 and a53 revealed that the 5¢ and 3¢ breakpoints
of the ) )SA deletion were at nucleotides 19 915 and 696 of
the sequences with GenBank accession numbers Z84721
and Z69706, respectively, and the two breakpoints were
separated by an insertion of 157 bp of DNA that had
originated from elsewhere in the genome (Fig 3).
Analysis of Alu repeats in the breakpoints revealed that
the 5¢ breakpoint occurred in a 144 bp Alu Sg/x sequence
and the 3¢ breakpoint occurred in a 307 bp Alu Sx
sequence. The deletion removed 69 bases of 5¢ Alu Sgx
and 102 bases of 3¢Alu Sx along with the 23 kb
intervening sequence and bridged the two breakpoints with
157 bp of DNA. The inserted sequence had two sections of
Alu sequences; 59 bp at the 5¢ region with sequence
similarity to the Alu Yd3a1 sequence and 98 bp at the 3¢
region to Alu Sc. This rearrangement of deletion and
insertion of DNA changed the pattern of Alu sequences at
the region where the mutation occurred to Alu Sgx in the 3¢
region with three bases different from the original Alu Sgx
present in the normal a-globin gene cluster and Alu Sc in
the 5¢ region.
DISCUSSION
Only two cases of a-thalassaemia with ) )SA allele have
been reported so far. In this report we have described an
additional 13 Indian HbH patients with this mutation. This
suggests that this mutation is prevalent in the Indian
population, is more common than previously reported and
Table I. Sequence and location of primers used for PCR.
Primer Sequence 5¢–3¢ Location
20Æ5-F* GCCCAACATCCGGAGTACATG 17904–17924 in Z84721
THAI R* CAAGTGGGCTGAGCCCTTGAG 1241–1221 in Z69706
SEA R* AGCCCACGTTGTGTTCATGGC 3817–3797 in Z69706
FIL R* ATAACCTTTATCTGCCACATGTAGC 570–546 in Z69706
a52 CTCTTTCTCTCGGAGCCCTT 19286–19303 in Z84721
a53 ACTCGAGCTACCCCAAGGAT 975–956 in Z69706
*Primers described by Tan et al (2001).
Table II. Sequence and location of the primers used for sequencing.
Primer Sequence 5¢–3¢ Location
a50 GCAGTGGGACAATCTTGGTT 19656–19675 in Z84721
a56 TGGTAGCCTGTAATCCCAGC 19835–19854 in Z84721
a55 CTCAGCTCACACCAACCTCC 826–807 in Z69706
Fig 2. Nucleotide sequencing results showing a novel splice donor
site mutation IVS I-1 (G fi A), which was found in the compound
heterozygous state with ) )SA deletion in three siblings with HbH
disease. The arrow indicates the position of the mutation.
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is, in fact, the most common a-thalassaemia determinant
causing HbH disease in India.
The a-globin gene cluster is interspersed with Alu-family
repeats, which are commonly associated with DNA recom-
bination. Most of the deletions causing a-thalassaemia are
simple linear chromosomal deletions between two highly
homologous Alu repeats in the a-globin gene cluster. In the
deletion ) )MED there was an insertion of a new section of
DNA, originating from upstream of the a-globin gene cluster,
bridging the two breakpoints (Nicholls et al, 1987). The
inserted DNA appears to have been incorporated into the
junction in a manner which suggests that the upstream
Table III. The origin, haematological and genetic data of patients with the ) )SA deletion.
Family/patient no. Relationship
Age
(years) Origin Hb (g/dl) MCV (fl) MCH (pg) HbF (%) HbA2 (%) a-globin genotype
Family
1 Propositus 38 West Bengal 8Æ4 62 18Æ1 0Æ2 1Æ6 )a3Æ7/) )SA
Father 60 12Æ9 80Æ7 26Æ3 0Æ2 3Æ3 )a3Æ7/aa
Mother 50 11Æ2 67Æ7 19Æ3 0Æ3 2Æ3 aa/) )SA
Daughter 1 4 10Æ6 59Æ8 21Æ1 0Æ1 3Æ1 aa/) )SA
Daughter 2 7 12Æ7 83Æ9 25Æ5 0Æ2 2Æ6 )a3Æ7/aa
Sister 1 35 12Æ6 85Æ7 27Æ9 0Æ2 2Æ8 aa/aa
Sister 2 35 13Æ5 71Æ8 21Æ0 0Æ4 2Æ6 aa/) )SA
Sister 3 29 11Æ0 84Æ1 24Æ8 0Æ4 2Æ5 )a3Æ7/aa
Brother 27 9Æ8 59Æ6 17Æ0 0Æ2 1Æ8 )a3Æ7/) )SA
2 Propositus 13 Orissa 9Æ8 66Æ0 17Æ6 0Æ1 1Æ7 )a3Æ7/) )SA
Mother 42 12Æ8 87Æ8 28Æ3 0Æ1 2Æ4 )a3Æ7/aa
3 Propositus 6 West Bengal 8Æ3 56Æ8 17Æ3 na na )a4Æ2/) )SA
Father 32 12Æ6 77Æ6 25Æ0 0Æ1 2Æ4 )a3Æ7/aa
Mother 27 9Æ1 58Æ1 20Æ1 0Æ4 HbE ¼ 18Æ8 aa/) )SA
4 Propositus 23 West Bengal 7Æ7 67Æ4 19Æ8 1 1Æ7 aIVS I-1(G fi A)a/) )SA
Father 52 12Æ1 69Æ3 21Æ3 0Æ2 3Æ2 aIVS I-1(G fi A)a/aa
Mother 48 10Æ2 66Æ9 20Æ2 1Æ9 2Æ2 aa/) )SA
Brother 1 15 9Æ1 63Æ6 18Æ7 1 1Æ1 aIVS I-1(G fi A)a/) )SA
Sister 1 20 7Æ5 63Æ7 17Æ7 0Æ8 1Æ5 aIVS I-1(G fi A)a/) )SA
Individuals
1 26 Orissa 10Æ1 61Æ0 19Æ4 0Æ2 2Æ1 )a3Æ7/) )SA
2 15 Punjab 8Æ2 74Æ4 20Æ1 0Æ3 2Æ3 )a3Æ7/) )SA
3 42 West Bengal 9Æ2 64Æ1 18Æ5 0Æ7 2Æ0 )a4Æ2/) )SA
4 26 Madhya Pradesh 8Æ7 63Æ9 19Æ7 0Æ6 1Æ9 )a4Æ2/) )SA
5 33 West Bengal 9Æ5 59Æ6 19Æ1 0Æ4 1Æ9 )a3Æ7/) )SA
6 32 West Bengal 10Æ3 69Æ5 19Æ9 0Æ2 1Æ9 )a3Æ7/) )SA
na, not available/not analysed.
Fig 3. Alignment of the sequences surround-
ing the breakpoint of ) )SA deletion with the
normal sequences in the GenBank accessions
Z84721 and Z69706. The vertical bars show
identical nucleotides. The underlined region
indicates the inserted section of DNA that
bridged the breakpoints in the mutant chro-
mosome.
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segment lies close to the breakpoint regions during replica-
tion. Comparison of the mutant sequence in the ) )SA allele
across the breakpoint and the normal sequence in the
a-globin gene cluster showed that there was a deletion of
23 kb and an insertion of 157 bases at the breakpoint
junction. Sequence homology search of this inserted
sequence in the human genome carried out using FastaA
(http://www.dna.affrc.go.jp/htdocs/Blast/fasta.html) found
that the reverse complementary sequence, which has a close
similarity (155 of the 157 nucleotides) to the inserted
sequence in the breakpoints, is present in chromosome 16 in
the nucleotides 66097–66253 of the sequence with Gen-
Bank accession number AC007604. In this location, these
DNA sequences lie in an Alu Sc-Alu Sx sequence with part of
the sequences in the Alu Sc and part of the sequence in Alu
Sx. However, the exact physical location and orientation of
this sequence (GenBank accession number AC007604) from
the a-globin gene cluster is not yet available. It is possible
that a mechanism similar to that involved in ) )MED is
responsible for the origin of ) )SA mutation. As the inserted
fragment has Alu sequences, it may also be possible that a
homologous recombination between the Alu sequences,
present near the breakpoint of the deletion and those present
elsewhere in chromosome 16, is responsible for the deletion
and insertion of DNA in this mutation.
It was confirmed that the amplified product with the
primers a52 and a53 was from the chromosome carrying the
) )SA deletion, as the amplification was only obtained in
those patients whose haematological parameters indicated a
possible a-thalassaemia-1 mutation. Among those who were
compound heterozygous for ) )a3Æ7/) )SA, there was no
amplification of the a2 gene, which was used as an internal
control to amplify a-globin gene without any deletions. This
is well illustrated by the analysis of a large family with 10
members, of whom two had HbH disease (Fig 4).
Isolated cases of HbH disease have been reported in the
Indian population. The present study analysed 17 HbH
patients in the Indian population for the underlying geno-
types and showed that compound heterozygosity for single
and double gene deletions in the a-globin gene cluster
() )a/) )) is the most common genotype that causes HbH
disease in this population, as in other populations. The
modified multiplex PCR should simplify and subsequently
reduce the cost of screening for a-thalassaemia deletions in
suspected cases, particularly for the molecular diagnosis of
HbH disease and prenatal diagnosis of Hb Bart’s disease.
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